Guardant Health, Inc. (1GH)
MTA
140.22
-6.12 (-4.18%)
Real-time Data
07:00 AM
Day's Range
140.22147.36
52 wk Range
42.00153.70
Financial Statements - 1GH - Guardant Health, Inc.
Revenue
982.02M▲ 57.0%
Net Income
-416.27M▼ 12.7%Net Margin -42.4%
EBITDA
-373.90M▼ 13.2%
Free Cash Flow
-233.06M▼ 0.1%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Sales | 982.02M | 625.65M |
| Cost of Goods | 349M | 245.34M |
| Gross Profit | 633.01M | 380.30M |
 Operating Expense | - | - |
| Operating Income | -437.24M | -375.54M |
| Non-Operating Interest | - | - |
| Other Income Expense | -10.49M | -36.06M |
| Pre Tax Income | -417.54M | -368.34M |
| Income Tax | -1.26M | 1.08M |
| Net Income | -416.27M | -369.43M |
| EPS Basic | -3.32 | -3.56 |
| EPS Diluted | -3.32 | -3.56 |
| Basic Shares Outstanding | 125.37M | 103.91M |
| Diluted Shares Outstanding | 125.37M | 103.91M |
| Ebit | -413.64M | -366.16M |
| Ebitda | -373.90M | -330.27M |
| Net Income Continuous Operations | -416.27M | -369.43M |
| Minority Interests | - | - |
| Preferred Stock Dividends | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
